Cas 1105663-16-8,1,1-dimethyl-3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-prop-2-ynylamine

1105663-16-8

Post Buying Request

Basic information

Product Name: 1,1-dimethyl-3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-prop-2-ynylamine
Synonyms: 1,1-dimethyl-3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-prop-2-ynylamine
CAS NO:1105663-16-8
Molecular Formula:
Molecular Weight: 285.194
EINECS: N/A
Product Categories: N/A
Mol File: 1105663-16-8.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 1,1-dimethyl-3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-prop-2-ynylamine(CAS DataBase Reference)
NIST Chemistry Reference: 1,1-dimethyl-3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-prop-2-ynylamine(1105663-16-8)
EPA Substance Registry System: 1,1-dimethyl-3-[4-(4,4,5,5-tetramethyl-[1,3,2]dioxaborolan-2-yl)-phenyl]-prop-2-ynylamine(1105663-16-8)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 1105663-16-8(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

1105663-16-8 Suppliers

Recommended suppliersmore

1105663-16-8 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 1105663-16-8 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,0,5,6,6 and 3 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1105663-16:
(9*1)+(8*1)+(7*0)+(6*5)+(5*6)+(4*6)+(3*3)+(2*1)+(1*6)=118
118 % 10 = 8
So 1105663-16-8 is a valid CAS Registry Number.

1105663-16-8Upstream product

1105663-16-8Downstream Products

1105663-16-8Relevant articles and documents

HETEROCYCLIC COMPOUNDS USEFUL AS MK2 INHIBITORS

-

Page/Page column 56, (2009/03/07)

The present invention describes tetracyclic compounds of formula (IA) or (IB), wherein the symbols R, X, A, Y, R2, R3 and D are as defined in the specification, their use in the treatment of certain diseases, e.g. depending on MK-2 or TNF activity, and wa

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 1105663-16-8